Acetazolamide assisted Tc-99m MAG3 renography to assess renal blood flow reserve

Annals of Nuclear Medicine

Volumn 17, Issue 2, 2003, Pages 139-144

  Horita, Yoshio ^a,c   Hayashida, Kohei ^a   Fukuchi, Kazuki ^a   Takishita, Shuichi ^b   Tadokoro, Masato ^c   Taura, Kouichi ^c   Suyama, Naofumi ^c   Miyazaki, Masanobu ^d   Kohno, Shigeru ^d   Kawano, Yuhei ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c Nagasaki Municipal Medical Center   (Japan)

^d NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetazolamide; Microangiopathy; Tc 99m MAG3 renography; Vasoreactivity

Indexed keywords

ACETAZOLAMIDE; MERTIATIDE TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY CORTEX; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENOGRAPHY; TECHNIQUE;

EID: 12444262880     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02988452     Document Type: Article

References (24)

1. Taki K, Hirahara K, Tomita S, Totoki T. Acetazolamide-induced increase in blood flow to rabbit organ is confirmed using colored microspheres. Heart Vessels 1998; 13: 63-67.
2. Taki K, Kato H, Endo S, Inada K, Totsuka K. Cascade of acetazolamide-induced vasodilatation. Res Commun Mol Pathol Pharmacol 1999; 103: 240-248.
3. 15O-water measurement. Nucl Med Commun 1996; 17: 1047-1051.
4. Horita Y, Hayashida K, Takishita S, Kohno S, Kawano Y. Dilatation of renal artery distal to stenosis demonstrated using acetazolamide Tc-99m MAG3 scintigraphy. Clin Nucl Med 2001; 26: 795-796.
5. Helmchen U, Wenzel UO. Benign and malignant nephrosclerosis and renovascular disease. In: Renal pathology: with clinical and functional correlations, Tisher CC, Brenner BM (eds), Philadelphia; JB Lippincott Company, 1994: 1201-1236.
6. Williams PS, Foss G, Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med 1988; 252: 343-354.
7. Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 1999; 34: 973-995.
8. Parving HH, Mogensen CE, Jensen HE, Evering PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974; 1: 1190-1192.
9. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 21: 1080-1084.
10. 99mTc MAG3 [Abstract]. J Nucl Med 2001; 42 (Suppl): p41.
11. Taylor A Jr, Manatunga A, Morton K, Reese L, Prato F, Greenberg E, et al. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. Radiology 1997; 204: 47-54.
12. Itoh K, Nonomura K, Yamashita T, Kanegae K, Murakumo M, Koyanagi T, et al. Quantification of renal function with a count-based gamma camera method using Technetium-99m-MAG3 in children. J Nucl Med 1996; 37: 71-75.
13. 99mTc-MAG3 renography without blood sampling. J Nucl Med 1999; 40: 793-798.
14. Bosch JP. Renal reserve: a functional view of glomerular filtration rate. Semin Nephrol 1995; 15: 381-385.
15. Taki K, Oogoshi K, Hirahara K, Gai X, Nagashima F, Tozuka K. Preferential acetazolamide-induced vasodilation based on vessel size and organ: confirmation of peripheral vasodilation with use of colored microspheres. Angiology 2001; 52: 483-488.
16. Skott P, Hommel E, Bruun NB, Arnord-Larsen S, Parving HH. Effects of acetazolamide on kidney function in Type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1988; 31: 806-810.
17. Hannedouche T, Lazaro M, Delgado AG, Boitard C, Lacour B, Grunfeld J-P. Feedback-mediated reduction in glomerular filtration during acetazolamide infusion in insulin-dependent diabetic patients. Clin Sci 1991; 81: 457-464.
18. Slomowitz LA, Bergamo R, Hirschberg R, Grosvenor M, Kopple JD. Enalapril attenuates the renal hemodynamic effect of acetazolamide in patients with diabetes mellitus: possible implications for tubuloglomerular feedback. Am J Nephrol 1996; 16: 315-319.
19. Tucker BJ, Steiner RW, Gushwa LC, Blantz RC. Studies on the tubular-glomerular feedback system in the rat. The mechanism of reduction in filtration rate with benzolamide. J Clin Invest 1978; 62: 993-1004.
20. Leyssac PP, Karlsen FM, Skott O. Dynamics of intrarenal pressures and glomerular filtration rate after acetazolamide. Am J Physiol 1991; 266: R1544-R1550.
21. Leyssac PP, Karlsen FM, Holstein-Rathlou NH, Skott O. On determinants of glomerular filtration rate after inhibition of proximal tubular reabsorption. Am J Physiol 1991; 261: F169-F178.
22. Smith HW. Structure and function of the kidney. In: Clinical Nephrology, Papper S (eds), Boston, Massachusetts; Little, Brown and Company, 1978: 35-90.
23. Christensen PK, Hansen HP, Parving HH. Impaired auto-regulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney Int 1997; 52: 1369-1374.
24. Shimotsu Y, Hayashida K, Kume N, Fukuchi K, Nishimura T. Acetazolamide induced myocardial ischemia in patients with severe coronary artery disease. Ann Nucl Med 1997; 12: 21-27.